Hand, Foot and Mouth Disease Clinical Trial
Official title:
A Serosurvey Study of Hand, Foot, and Mouth Disease in Healthy Children Aged 6 to 71 Months Old in Bandung and West Bandung District, Indonesia
This study is a sero-survey study of infants aged 6 months to 71 months in Bandung City and West Bandung District. As initial data to find out how many children have been exposed to human enterovirus type 71 (HEV-71) which causes Hand, foot, and mouth disease (HFMD).
This study is a cross-sectional seroprevalence survey of EV-71, associated with HFMD, among children aged between 6 to 71 months in Bandung, sampled from urban and rural Primary Health Center in Bandung, Indonesia. This study was implemented by Department of Child Health Hasan Sadikin General Hospital/Medical Faculty Universitas Padjadjaran Bandung, West Java. Age-stratified sample of 600 children aged 6-71 months will be conducted from these sites. Samples testing includes routine blood counts, enzyme-linked immunosorbent assays (ELISAs) for enterovirus type 71 (EV71) IgG and ELISAs for other HFMD-associated enteroviruses. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06063057 -
Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial
|
Phase 1/Phase 2 | |
| Completed |
NCT04133584 -
The Immunogenicity and Safety of the Vaccination of Inactivated Enterovirus 71 Vaccine and Seasonal Influenza Vaccine
|
Phase 4 | |
| Completed |
NCT03241030 -
Sucralfate to Improve Oral Intake in Children With Infectious Oral Ulcers: a Randomized, Double-blind, Placebo-Controlled Trial
|
Phase 2 | |
| Completed |
NCT01255124 -
Study on Dynamic Changes of the Maternal Anti-EV71 and Anti-CVA16 Antibody Levels in Infants and Young Children
|
N/A | |
| Completed |
NCT03873740 -
Immunogenicity and Safety of Two Different Commercial EV71 Vaccines
|
Phase 4 | |
| Recruiting |
NCT06146088 -
Lot-to-lot Consistency Study of Three Commercial Batches of Enterovirus 71 Vaccine
|
Phase 4 | |
| Active, not recruiting |
NCT06209398 -
Immunogenicity of the Inactivated EV71 Vaccine Combined With Hepatitis B and Group A Meningococcal Vaccine
|
Phase 4 | |
| Recruiting |
NCT01175915 -
A Clinical Trial To Evaluate Reduning Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease
|
N/A | |
| Recruiting |
NCT01145664 -
A Multi-Center Clinical Trial To Evaluate Chinese Herbal Medicines in the Treatment of Severe Hand-foot-mouth Disease
|
N/A | |
| Completed |
NCT01182532 -
A Clinical Trial to Evaluate the Effectiveness and Safety of Chinese Medicine in the Treatment of Mild Type of Hand, Foot, and Mouth Disease
|
N/A | |
| Completed |
NCT03281174 -
Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) Vaccine
|
N/A | |
| Completed |
NCT03582761 -
Efficacy Evaluation for Inactivated Vaccine (Vero Cell) Against EV71
|
Phase 4 | |
| Completed |
NCT03903926 -
Efficacy Trial of a Commercial EV71 Vaccine
|
Phase 4 | |
| Completed |
NCT02001233 -
A Follow-up Study for a Phase III, Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine
|
||
| Completed |
NCT03909074 -
Clinical Trial of Enterovirus 71（EV71） Inactivated Vaccine in Children Aged 36-71 Months
|
Phase 3 | |
| Completed |
NCT01769794 -
Chinese Medicinal Treatment on Mild Hand, Foot, and Mouth Disease: Multicenter, Prospective, Randomized Double-blind, Placebo-controlled Study
|
N/A | |
| Recruiting |
NCT01182025 -
A Clinical Trial to Evaluate the Effectiveness and Safety of Xiyanping Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease
|
N/A | |
| Recruiting |
NCT06263439 -
Surveillance of HFMD in Pediatric Outpatients
|
||
| Not yet recruiting |
NCT05397587 -
An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell)
|
Phase 4 | |
| Completed |
NCT04111432 -
Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With Expanded Programme on Immunization Vaccines
|
Phase 4 |